Eric M. Dube, Chief Executive Officer at Travere Therapeutics, Inc. (TVTX), sold 34,664 shares at $30.43 ($1.0M) on 2022-01-04, disclosed to the SEC on 2022-01-06.
Open-market sale of $1.0M TVTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.43 | 4,832 | $147K | 14.1% |
| 2 | $30.43 | 4,832 | $147K | 14.1% |
| 3 | $29.84 | 10,361 | $309K | 29.6% |
| 4 | $29.84 | 10,361 | $309K | 29.6% |
| 5 | $30.48 | 2,139 | $65K | 6.3% |
| 6 | $30.48 | 2,139 |
| $65K |
| 6.3% |
| Total | $30.08 avg | 34,664 | $1.0M | 100% |
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.6M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $1.9M | — | Filing → |
| TVTX | SELL | 2026-02-24 | $1.8M | — | Filing → |